Management of atrial fibrillation: therapeutic options and clinical decisions (Q33902710)

29 July 2017

1 reference

title

Management of atrial fibrillation: therapeutic options and clinical decisions (English)

1 reference

29 July 2017

1 reference

Prystowsky EN

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

American Journal of Cardiology

29 July 2017

published in

1 reference

29 July 2017

volume

85

1 reference

29 July 2017

issue

10A

1 reference

29 July 2017

page(s)

3D-11D

1 reference

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Management of atrial fibrillation: simplicity surrounded by controversy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

A COMPUTER MODEL OF ATRIAL FIBRILLATION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

High-density mapping of electrically induced atrial fibrillation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Pathology of atrial fibrillation in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Experimental studies on auricular flutter and auricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Mechanism of flutter and fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

A focal source of atrial fibrillation treated by discrete radiofrequency ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Atrial fibrillation: nonpharmacologic approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Drug choices in the treatment of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Electrical remodeling in atrial fibrillation. Time course and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Verapamil reduces tachycardia-induced electrical remodeling of the atria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Management and prevention of atrial fibrillation after cardiovascular surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2900908-5

10.1016/S0002-9149(00)00908-5

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference